Quick Answer
Outset Medical, Inc. reported Net Income Loss of -$81.65 million for the year ending 2025.
- Outset Medical, Inc. showed an increase of +36.2% in Net Income Loss from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$16.42 million | Q2 2019: -$17.03 million | Q3 2019: -$15.40 million | Q4 2019: -$19.45 million | Q1 2020: -$20.65 million | Q2 2020: -$26.51 million | Q3 2020: -$42.29 million | Q4 2020: -$32.04 million | Q1 2021: -$30.03 million | Q2 2021: -$30.21 million | Q3 2021: -$30.47 million | Q1 2022: -$36.89 million | Q2 2022: -$43.84 million | Q3 2022: -$40.78 million | Q1 2023: -$43.97 million | Q2 2023: -$44.05 million | Q3 2023: -$46.18 million | Q1 2024: -$39.94 million | Q2 2024: -$34.45 million | Q3 2024: -$27.94 million | Q1 2025: -$25.78 million | Q2 2025: -$18.54 million | Q3 2025: -$17.84 million.
- Over the full 8 years of available data (2018 to 2025), Outset Medical, Inc.'s Net Income Loss has declined by 64.0%.
- Historical annual values: Fiscal year 2025: -$81.65 million | Fiscal year 2024: -$127.98 million | Fiscal year 2023: -$172.80 million | Fiscal year 2022: -$162.96 million | Fiscal year 2021: -$131.94 million | Fiscal year 2020: -$121.49 million | Fiscal year 2019: -$68.30 million | Fiscal year 2018: -$49.78 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: